Administrating statins to patients with diastolic heart failure increases the survival rate by 22% compared to patients receiving other drugs.
William C. Little and his research team from Wake Forest University, has found that patients with diastolic heart failure (DHF) treated with statins has better survival rates. The study was done on 137 diastolic heart failure patients published in the Journal Circulation: Journal of the American Heart Association. Diastolic heart failure occurs as the heart does not fully relax and therefore does not fill properly with blood. The mortality occurring due to DHF is 5-8%. Once hospitalized, patients with diastolic heart failure have a 50 percent chance of re-hospitalization within six months. It's estimated that the cost of treating patients for diastolic heart failure exceeds $3.5 billion a year.
William C. Little reports, "Some patients in the group had been diagnosed with high cholesterol and placed on statin therapy by their doctors. Others in the group whose cholesterol levels were not as high in general, were not placed on statins," Little and his research team found that during the study period, heart failure patients on statin therapy had a risk of death that was 22 percent lower than the patients receiving the other drugs. Even after adjusting for other factors that could have affected the results, such as hypertension or cardiovascular disease, the heart failure patients on statins still fared better.
The better survival of these patients is due to the beneficial effects of statins in DHF patients.
Source : (Newswise)
Further Information on Heart disease from Medindia
Chest pain is a common symptom which can be caused by many different conditions. Some causes of chest pain require prompt medical attention, such as angina, heart attack, or tearing of the aorta. Other causes of chest pain can be evaluated electively, such as spasm of the esophagus, gallbladder attack, or inflammation of the chest wall.
For more information: